4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0000905148-23-000853
Chief Regulatory Officer sold 5,000 shares at an average $54.76 ($273,804)
- Chief Regulatory Officer acquired 5,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karp Carol D. Chief Regulatory Officer | 2023-09-06 | Option exercise 10b5-1 | +5,000 | $12.15 | $60,750 | 5,000 | D: show line 1 in the form |
| Karp Carol D. Chief Regulatory Officer | 2023-09-06 | Sale 10b5-1 | −4,994 | $54.76 | $273,472 | 6 | D: show line 2 in the form |
| Karp Carol D. Chief Regulatory Officer | 2023-09-06 | Sale 10b5-1 | −6 | $55.27 | $332 | 0 | D: show line 3 in the form |
| Open-market sales · 5,000 sh · avg $54.76 · $273,804 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Karp Carol D. Chief Regulatory Officer | 2023-09-06 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,000 | 50,000 | D: show line 4 in the form |
Loading xslF345X05/form4.xml…